Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, Decision Biomarkers


GE Healthcare this week launched its illustra GenomiPhi HY DNA Amplification Kit and the illustra GenomiPhi V2 DNA Amplification Kit, both of which it recommends for genomic DNA preparation.

According to GE, the illustra GenomiPhi kits provide a method for genomic DNA stock replenishment and for DNA preparation upstream of PCR, genotyping, array comparative genomic hybridization, and cloning applications. Both kits use GE Healthcare's Phi 29 DNA polymerase technology which is based on an isothermal method of whole genome amplification, the company said.

GE also said that the GenomiPhi HY kit is a new offering for midi-scale DNA preparation, while the GenomiPhi V2 kit replaces GE Healthcare's original GenomiPhi kit for small-scale DNA preparation.

Decision Biomarkers last week launched its 8-Plex Cytokine Max Biochip that the company claims enables drug researchers to test for eight standard biomarkers linked to several inflammatory disorders at the same time.

The company also announced the availability of its iMark Biochip for use in customizable assays.

Both biochips are used in the Avantra Q400 Biomarker Workstation, DBI's flagship multiplexed-immunoassay system, which was formerly called the MultiMark Express.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.